Immunogenicity and Safety Among Children and Adults of the 2009-2010 Trivalent Influenza Vaccine, 2008-2009 Trivalent Influenza Vaccine, and Quadrivalent Influenza Vaccine (Intramuscular Route).
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 22 Oct 2012 An overview of results from the quadrivalent influenza vaccine trials, including this trial, was presented at IDWeek, according to a Sanofi Pasteur media release.
- 26 Oct 2010 Primary endpoint 'Geometric mean antibody titre' has been met.
- 26 Oct 2010 Results were presented at the 48th Annual Meeting of the Infectious Diseases Society of America, according to a Sanofi Pasteur media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History